These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30158570)

  • 1. The changing epidemiology of liver diseases in the Asia-Pacific region.
    Wong MCS; Huang JLW; George J; Huang J; Leung C; Eslam M; Chan HLY; Ng SC
    Nat Rev Gastroenterol Hepatol; 2019 Jan; 16(1):57-73. PubMed ID: 30158570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.
    Sarin SK; Kumar M; Eslam M; George J; Al Mahtab M; Akbar SMF; Jia J; Tian Q; Aggarwal R; Muljono DH; Omata M; Ooka Y; Han KH; Lee HW; Jafri W; Butt AS; Chong CH; Lim SG; Pwu RF; Chen DS
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):167-228. PubMed ID: 31852635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV.
    Liu CJ; Chen PJ
    Liver Int; 2022 Aug; 42(9):1945-1954. PubMed ID: 34402183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing epidemiology of hepatocellular carcinoma in Asia.
    Goh GB; Chang PE; Tan CK
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):919-28. PubMed ID: 26651253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of four common non-infectious liver diseases for the hospitalized patients in Beijing 302 hospital from 2002 to 2013.
    Chang B; Li B; Huang A; Sun Y; Teng G; Wang X; Liangpunsakul S; Li J; Zou Z
    Alcohol; 2016 Aug; 54():61-5. PubMed ID: 27519542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
    Yang M; Wei L
    Liver Int; 2022 Aug; 42(9):1981-1990. PubMed ID: 35373500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-Analysis.
    Martinello M; Amin J; Matthews GV; Dore GJ
    AIDS Rev; 2016; 18(2):68-80. PubMed ID: 27196354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in Asia: emerging perspectives.
    Seto WK; Yuen MF
    J Gastroenterol; 2017 Feb; 52(2):164-174. PubMed ID: 27637587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future liver of the Asia pacific: fatter and firmer from more fructose and fortune?
    Mahady SE; George J
    J Clin Exp Hepatol; 2013 Jun; 3(2):106-13. PubMed ID: 25755484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment.
    Chu CJ; Lee SD
    J Gastroenterol Hepatol; 2008 Apr; 23(4):512-20. PubMed ID: 18397482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis C in Asia: when East meets West.
    Yu ML; Chuang WL
    J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosomiasis, hepatitis B and hepatitis C co-infection.
    Gasim GI; Bella A; Adam I
    Virol J; 2015 Feb; 12():19. PubMed ID: 25889398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
    Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D
    Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region.
    Danpanichkul P; Suparan K; Sukphutanan B; Kaeosri C; Tothanarungroj P; Sirimangklanurak S; Kalligeros M; Polpichai N; Pang Y; Wijarnpreecha K; Sripongpun P; Chamroonkul N; Nguyen MH; Liangpunsakul S; Piratvisuth T; Kaewdech A
    Sci Rep; 2024 Aug; 14(1):19544. PubMed ID: 39174722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of hepatitis B and C virus infections in Asia.
    Huy TT; Abe K
    Pediatr Int; 2004 Apr; 46(2):223-30. PubMed ID: 15056256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of chronic liver diseases in the USA in the past three decades.
    Younossi ZM; Stepanova M; Younossi Y; Golabi P; Mishra A; Rafiq N; Henry L
    Gut; 2020 Mar; 69(3):564-568. PubMed ID: 31366455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effective options for the prevention and management of gastrointestinal and liver disease in the Asia-Pacific region.
    Roberts-Thomson IC; Lung T
    J Gastroenterol Hepatol; 2018 Jan; 33(1):121-127. PubMed ID: 28833619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.